Archive · 1 Aug 2025
Dr. Lal PathLabs Q1 Profit Up 24%, Eyes Southern Expansion
Dr. Lal PathLabs, a company that does medical tests, had a good financial quarter!
Their profit went up a lot, by 24%, reaching ₹132 crore.
This is more than what experts thought it would be.
The company is also planning to grow by expanding in the southern part of the country and possibly buying other companies.
Dr. Lal PathLabs' consolidated net profit rose 24% year-over-year to ₹132 crore in Q1 2025.
The profit increase was from ₹106.4 crore in the same quarter the previous year.
This profit exceeded street estimates of ₹122.76 crore.
Dr. Lal PathLabs is considering expanding its operations in southern India.
The company is also assessing potential acquisition opportunities.
- Who
- Dr. Lal PathLabs, a healthcare diagnostics company.
- What
- Dr. Lal PathLabs reported a 24% increase in consolidated net profit for Q1 2025.
- When
- The financial results are for the April-June 2025 quarter.
- Where
- The company operates diagnostic services across India and is looking to expand in the South.
- Why
- The articles do not specify why the profit increased.
- Net Profit (Q1 2025)
- ₹132 crore
- Net Profit (Q1 2024)
- ₹106.4 crore
- Net Profit Growth (YoY)
- 24%
- Street Estimate (Q1 2025)
- ₹122.76 crore
